Abstract
Background
We developed the Canadian Syncope Pathway (CSP) based on the Canadian Syncope Risk Score (CSRS) to aid emergency department (ED) syncope management. This pilot implementation study assessed patient inclusion, length of transition period, as well as process measures (engagement, reach, adoption, and fidelity) to prepare for multicenter implementation.
Methods
A non-randomized stepped wedge trial at two hospitals was conducted over a 7-month period. After 2–3 months in the control condition, the hospitals crossed over in a stepwise fashion to the intervention condition. Study participants were ED and non-ED physicians, or their delegates, and patients (aged ≥ 18 years) with syncope. We aimed to analyze patient characteristics, ED management including disposition decision, and CSRS recommendations application for all eligible patients during the intervention period. Our targets were 95% inclusion rate, 70% adoption (proportion of physicians who applied the pathway), 60% reach (intervention applied to eligible patients) and 70% fidelity (appropriate recommendations application) for all eligible patients. Clinical Trials registration NCT04790058.
Results
1002 eligible patients (mean age 56.6 years; 51.0% males) were included: 349 patients during the control and 653 patients during the intervention period. Physician engagement varied from 39.7% to 97.1% for presentation at meetings. Process measures for the first month and the end of the intervention were: adoption 70.7% (58/82) and 84.4% (103/122), reach 67.5% (108/160) and 55.0% (359/653), fidelity among patients with physician data form completion 86.3% (88/102) and 88.3% (294/333), versus fidelity among all eligible patients 83.8% (134/160) and 83.3% (544/653) respectively with no significant differences in fidelity at one month and the end of the intervention period.
Conclusion
In this pilot study, we achieved all prespecified benchmarks for proceeding to the multicenter CSP implementation except reach. Our results indicate a 1-month transition period will be adequate though regular reminders will be needed during full-scale implementation.
Résumé
Contexte
Nous avons mis au point la Canadian Syncope Pathway (CSP) basée sur le Canadian Syncope Risk Score (CSRS) pour aider les services d’urgence à gérer la syncope. Cette étude pilote de mise en œuvre a évalué l’inclusion des patients, la durée de la période de transition, ainsi que les mesures de processus (engagement, portée, adoption et fidélité) pour se préparer à la mise en œuvre multicentrique
Méthodes
Un essai par étapes non randomisé dans deux hôpitaux a été mené sur une période de 7 mois. Après 2 à 3 mois dans l’état de contrôle, les hôpitaux sont passés progressivement à l’état d’intervention. Les participants à l’étude étaient des médecins du service de l’urgence et non du service de l’urgence, ou leurs délégués, et des patients (âgés de 18 ans) atteints de syncope. Nous avons cherché à analyser les caractéristiques des patients, la prise en charge des urgences, y compris la décision de disposition, et l’application des recommandations du CSRS pour tous les patients admissibles pendant la période d’intervention. Nos cibles étaient le taux d’inclusion de 95 %, l’adoption de 70 % (proportion de médecins qui ont appliqué la voie), la portée de 60 % (intervention appliquée aux patients admissibles) et la fidélité de 70 % (application des recommandations appropriées) pour tous les patients admissibles. Enregistrement des essais cliniques NCT04790058.
Résultats
1002 patients éligibles (âge moyen 56,6 ans; 51,0% d’hommes) ont été inclus : 349 patients pendant le contrôle et 653 patients pendant la période d’intervention. La participation des médecins variait de 39,7 % à 97,1 % pour la présentation aux réunions. Les mesures du processus pour le premier mois et la fin de l’intervention étaient les suivantes : adoption 70,7 % (58/82) et 84,4 % (103/122), atteinte de 67,5 % (108/160) et 55,0 % (359/653), fidélité chez les patients ayant rempli le formulaire de données médicales 86,3 % (88/102) et 88,3 % (294/333), versus fidélité chez tous les patients admissibles 83,8 % (134/160) et 83,3 % (544/653) respectivement, sans différence significative de fidélité à un mois et à la fin de la période d’intervention.
Conclusion
Dans cette étude pilote, nous avons atteint tous les points de repère prédéterminés pour procéder à la mise en œuvre du PSC multicentrique, sauf la portée. Nos résultats indiquent qu’une période de transition d’un mois sera adéquate, bien que des rappels réguliers seront nécessaires pendant la mise en œuvre à grande échelle.
Similar content being viewed by others
Data availability
Data can be made available after appropriate data sharing agreements are in place.
References
Thiruganasambandamoorthy V, Taljaard M, Stiell IG, et al. Emergency department management of syncope: need for standardization and improved risk stratification. Intern Emerg Med. 2015;10(5):619–27.
Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;73(1):15–23.
Martin GJ, Adams SL, Martin HG, Mathews J, Zull D, Scanlon PJ. Prospective evaluation of syncope. Ann Emerg Med. 1984;13(7):499–504.
Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. N Engl J Med. 1983;309(4):197–204.
Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668–71.
Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco syncope rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004;43(2):224–32.
Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006;47(5):448–54.
Birnbaum A, Esses D, Bijur P, Wollowitz A, Gallagher EJ. Failure to validate the San Francisco Syncope Rule in an independent emergency department population. Ann Emerg Med. 2008;52(2):151–9.
Sun BC, Mangione CM, Merchant G, et al. External validation of the San Francisco Syncope Rule. Ann Emerg Med. 2007;49(4):420–7.
Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010;55(8):713–21.
Thiruganasambandamoorthy V, Kwong K, Wells GA, et al. Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016;188(12):E289–98.
Thiruganasambandamoorthy V, Stiell IG, Sivilotti MLA, et al. Predicting short-term risk of arrhythmia among patients with syncope: the Canadian syncope arrhythmia risk score. Acad Emerg Med. 2017;24(11):1315–26.
Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, et al. Multicenter emergency department validation of the canadian syncope risk score. JAMA Intern Med. 2020;180(5):737–44.
Thiruganasambandamoorthy V, Yan JW, Rowe BH, et al. Personalised risk prediction following emergency department assessment for syncope. Emerg Med J 2021.
Hudek N, Brehaut J, Rowe B, Nguyen PA, Ghaedi B, Ishimwe AC, Fabian C, Yan JW, Sivilotti MLA, Le Sage N, Mercier E, Archambault P, Plourde M, Davis P, McRae AD, Hegdekar M, Thiruganasambandamoorthy V Development of practice recommendations based on the Canadian Syncope Risk Score and identification of barriers and facilitators for implementation PLOS ONE 2022; Submitted.
Rouleau G, Thiruganasambandamoorthy V, Wu K, Ghaedi B, Nguyen PA, Desveaux L A systematic approach to identifying and developing implementation strategies to support the uptake of a risk tool to aid in clinical management of patients with syncope: A qualitative study. JMIR Human Factors. 15/04/2023:44089 (forthcoming/in press)
Sun BC, Thiruganasambandamoorthy V, Cruz JD, Consortium to Standardize EDSRSR. Standardized reporting guidelines for emergency department syncope risk-stratification research. Acad Emerg Med 2012; 19(6): 694–702.
Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, et al. Duration of electrocardiographic monitoring of emergency department patients with syncope. Circulation. 2019;139(11):1396–406.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–7.
Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239.
Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1.
Acknowledgements
We are deeply indebted to all the patients who participated in this study and gratefully acknowledge the emergency physicians at the study sites who recruited the patients and the emergency medicine residents who helped in this process. We acknowledge the following members of our research team: Jane Jungyoon Park, Komal Valliani, Anton Saarimaki and Dong Vo from The Ottawa Methods Centre. We would also like to thank Dr. Phong Hong Vu, PhD for his help with statistical analysis. Dr. Thiruganasambandamoorthy is supported through a Physicians’ Services Incorporated Foundation Mid-Career Clinical Researcher award and University of Ottawa Tier-1 Clinical Research Chair award. Drs. Eagles and Yadav are supported by the University of Ottawa Junior Clinical Research Chair awards. The funders take no responsibility for the design, conduct, results, or interpretations presented here.
Funding
The study was funded by the Cardiac Arrhythmia Network of Canada (IMPL-002) as part of the Networks of Centres of Excellence (NCE) and TOHAMO.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Prior Presentations
N/A.
Additional information
Communicated by Eddy Lang.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Thiruganasambandamoorthy, V., Keller, M., Nguyen, P.A.I. et al. Implementation of the Canadian syncope pathway: a pilot non-randomized stepped wedge trial. Can J Emerg Med 25, 808–817 (2023). https://doi.org/10.1007/s43678-023-00570-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43678-023-00570-7